A prospective single-arm feasibility study using preoperative ctDNA to tailor neoadjuvant chemotherapy for patients with colorectal or appendiceal adenocarcinoma

Dr. Smith received travel support for fellow education and personal education from Intuitive Surgical (August 2015 and April 2026). Dr. Smith served as a clinical advisor for Guardant Health (March 2019) Dr. Smith served as a clinical advisor for Foundation Medicine (April 2022) Dr. Smith served as a consultant and speaker for Johnson and Johnson (May 2022) -------- Dr. Smith served as a clinical advisor for Urogen (January 2025) Dr. Smith served as a clinical advisor for Regeneron (January 2025) Dr.